Articles

The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy

Department of Hematology, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Department of Hematology, Hospital Clínic, IDIBAPS, Barcelona
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona
Department of Biochemistry and Molecular Biology, University of Oviedo, Spain
Department of Biochemistry and Molecular Biology, University of Oviedo, Spain
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona;University of Barcelona, Spain
Department of Hematology, Hospital Clínic, IDIBAPS, Barcelona
Department of Hematology, Hospital Clínic, IDIBAPS, Barcelona
Vol. 99 No. 5 (2014): May, 2014 https://doi.org/10.3324/haematol.2013.099796